Dementia, Internal medicine, Alzheimer's disease, Cognition and Neuroscience are his primary areas of study. Cognitive decline is the focus of his Dementia research. His Internal medicine research is multidisciplinary, incorporating elements of Endocrinology and Surgery.
His work deals with themes such as Odds ratio, Genetics, Genome-wide association study, Genomics and Degenerative disease, which intersect with Alzheimer's disease. His research in Cognition intersects with topics in Developmental psychology and Audiology. His research integrates issues of Schizophrenia and Recall in his study of Neuroscience.
His primary scientific interests are in Dementia, Internal medicine, Disease, Cognitive decline and Cognition. His study looks at the relationship between Dementia and topics such as Gerontology, which overlap with Longitudinal study. His Internal medicine research includes themes of Endocrinology and Oncology.
The Amyloid research Frank Jessen does as part of his general Disease study is frequently linked to other disciplines of science, such as In patient, therefore creating a link between diverse domains of science. The Cognitive decline study combines topics in areas such as Audiology, Neuropsychology, Developmental psychology, Memory clinic and Clinical psychology. His biological study spans a wide range of topics, including Genetics and Genome-wide association study.
Frank Jessen focuses on Dementia, Cognitive decline, Disease, Internal medicine and Cognition. Frank Jessen has researched Dementia in several fields, including Gerontology, Effects of sleep deprivation on cognitive performance, Gene, Alzheimer's disease and Apolipoprotein E. The concepts of his Cognitive decline study are interwoven with issues in Neuropsychology, Memory clinic, Clinical psychology and Neuroscience, Depression.
The various areas that he examines in his Disease study include Hippocampal formation, Psychiatry and Epidemiology. His Internal medicine research includes elements of Placebo, Endocrinology, Oncology and Cardiology. Frank Jessen has included themes like Audiology, Mediterranean diet, Brain size, Stage and Atrophy in his Cognition study.
His scientific interests lie mostly in Dementia, Cognitive decline, Disease, Internal medicine and Alzheimer's disease. Frank Jessen interconnects Incidence, Gerontology, MEDLINE, Gene and Apolipoprotein E in the investigation of issues within Dementia. His Cognitive decline study incorporates themes from Epidemiology and Effects of sleep deprivation on cognitive performance, Cognition, Neuroscience, Depression.
His Epidemiology research integrates issues from Prevention of dementia, Psychiatry, Progressive cognitive decline, Clinical psychology and Risk factor. His Disease research is multidisciplinary, incorporating perspectives in Hippocampal formation and Magnetic resonance imaging. His Internal medicine study integrates concerns from other disciplines, such as Geriatric Depression Scale and Oncology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (Nature Genetics (2009) 41 (1088-1093))
D Harold;R Abraham;P Hollingworth;R Sims.
Nature Genetics (2013)
The characterisation of subjective cognitive decline
Frank Jessen;Frank Jessen;Rebecca E Amariglio;Rachel F Buckley;Rachel F Buckley;Wiesje M van der Flier.
Lancet Neurology (2020)
Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.
Markus P. Kummer;Michael Hermes;Andrea Delekarte;Thea Hammerschmidt;Thea Hammerschmidt.
Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load.
Jens Wiltfang;Hermann Esselmann;Mirko Bibl;Michael Hüll.
Journal of Neurochemistry (2007)
Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment
Lukas Scheef;Annika Spottke;Moritz Daerr;Alexius Joe.
Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors
Alexander Semmler;Catherine Nichols Widmann;Thorsten Okulla;Horst Urbach.
Journal of Neurology, Neurosurgery, and Psychiatry (2013)
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Piotr Lewczuk;Peter Riederer;Sid E. O’Bryant;Marcel M. Verbeek.
World Journal of Biological Psychiatry (2018)
Risk of dementia in elderly patients with the use of proton pump inhibitors
Britta Haenisch;Britta Haenisch;Britta Haenisch;Klaus von Holt;Birgitt Wiese;Jana Prokein.
European Archives of Psychiatry and Clinical Neuroscience (2015)
A novel Alzheimer disease locus located near the gene encoding tau protein
G. Jun;C. A. Ibrahim-Verbaas;M. Vronskaya;J-C Lambert;J-C Lambert;J-C Lambert.
Molecular Psychiatry (2016)
A peripheral epigenetic signature of immune system genes is linked to neocortical thickness and memory
Virginie Freytag;Tania Carrillo-Roa;Annette Milnik;Philipp G. Sämann.
Nature Communications (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: